Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T22995 | ||||
Target Name | Hepcidin | ||||
Synonyms | Hepc20; Hepc25; Hepcidin20; LEAP1; Liverexpressed antimicrobial peptide 1; PLTR; Putative liver tumor regressor; HAMP | ||||
Target Type | Clinical Trial | ||||
Gene Name | HAMP | ||||
Biochemical Class | Hepcidin family | ||||
UniProt ID | HEPC_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Anemia | ||||
Example drug | NOX-H94 | Phase 2 | [532202], [1572592] | ||
Tissue | Bone marrow | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.18 Z-score: 0.47 P-value: 5.37E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.